Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (36): 5766-5771.doi: 10.3969/j.issn.2095-4344.1996

Previous Articles     Next Articles

Effects of intravenous tranexamic acid infusion combined with articular cavity injection on pain and early rehabilitation after knee arthroscopy

Wang Hairuo1, Liu Xi2, Li Mingjin1, Chen Xiaohua1, Liang Ting1, Ding Yongqing1, Tang Xiaoli1, Wang Ji1, Ma Huixu1
  

  1. 1Department of Orthopedics, Chongqing General Hospital, Chongqing 400021, China; 2Department of Radiology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing 400022, China
  • Online:2019-12-28 Published:2019-12-28
  • Contact: Ma Huixu, Master, Attending physician, Department of Orthopedics, Chongqing General Hospital, Chongqing 400021, China
  • About author:Wang Hairuo, Nurse-in-charge, Department of Orthopedics, Chongqing General Hospital, Chongqing 400021, China
  • Supported by:

    the Medical Research Program of the Health and Family Planning Commission of Chongqing City, No. 2017MSXM056 (to WJ)| the Science and Technology Foundation and Frontier Research Program of Yuzhong District of Chongqing City, No. 20150131 (to MHX)| the Medical Science and Technology Innovation Fund Project of Chongqing General Hospital, No. Y2017MSXM08 (to MHX)

Abstract:

BACKGROUND: Tranexamic acid could reduce bleeding after knee joint replacement, but there is still lack of reports about tranexamic acid on pain after arthroscopy.
OBJECTIVE: To investigate the effect of intravenous tranexamic acid infusion combined with articular cavity injection on pain and early rehabilitation after knee arthroscopy.
METHODS: From November 2016 to January 2018, 105 patients with meniscus injury who underwent knee arthroscopy in Chongqing General Hospital were included. The patients were randomly divided into injection group (simple articular cavity injection group), combined group (intravenous drip combined with articular cavity injection group) and control group. All patients signed the informed consent. This study was approved by the Hospital Ethics Committee. Visual analog scale score at rest was assessed at 6, 12, 24, 48, 72 hours postoperatively. Visual analog scale score at exercise was evaluated at 1, 3, 5, 7 days postoperatively. Range of motion of the knee was detected at 1, 3, 5, 7 days postoperatively. The number of use cases and dosage of remedial dizocine were recorded. Lysholm knee function score was compared before operation and during follow up after operation.
RESULTS AND CONCLUSION: (1) Visual analog scale score at rest was significantly higher in the injection group than in the combined group at 6, 12, 24 hours postoperatively (P < 0.05). There was no statistical difference at the rest time points (P > 0.05). (2) Visual analog scale score at exercise was higher in the injection group than in the combined group at 1 and 3 days (P < 0.05). There was no statistical difference at the rest time points (P > 0.05). (3) The dosage of remedial dizocine was less in the combined group than in the injection group  (P < 0.05). The range of motion of the knee was smaller in the injection group than in the combined group at 1, 3, 5, 7 days (P < 0.05). (4) There was no significant difference in Lysholm score between the injection group and the combined group in the last follow-up (P > 0.05). (5) Results suggested that intravenous tranexamic acid infusion combined with articular cavity injection can effectively relieve the early postoperative pain of arthroscopy and promote the early recovery of knee joint function.

Key words: meniscus injury, tranexamic acid, pain, arthroscopy, knee joint function, knee motion range, dizocine

CLC Number: